FiercePharmaAsia—China pharma market prospect, Hanmi’s negligence, Celgene’s Asia-Pacific collaboration

Posted: April 21st, 2017  |  Company/topic: Celgene
FiercePharmaAsia—China pharma market prospect, Hanmi’s negligence, Celgene’s Asia-Pacific collaboration aliu Fri, 04/21/2017 - 09:12…

Antengene Acquires East Asian Rights to Celgene Cancer Candidate

Posted: April 19th, 2017  |  Company/topic: Celgene
Antengene a oneyear old Shanghai startup has inlicensed China and East Asian rights to a Celgene cancer candidate. Celgene's TORC12 inhibitor is currently in several US Phase I trials in combination w…

Celgene in Asia-Pacific collab with Antengene, Tigermed as clinical support

Posted: April 17th, 2017  |  Company/topic: Celgene
Celgene in Asia-Pacific collab with Antengene, Tigermed as clinical support aliu Mon, 04/17/2017 - 23:28…

Celgene Notified of ANDA Filing for POMALYSTÂ

Posted: April 3rd, 2017  |  Company/topic: Celgene
Celgene Corporation NASDAQCELG has received a Paragraph IV Notice Letter advising that Teva Pharmaceuticals USA Inc. submitted an Abbreviated New Drug Application ANDA to the U.S. Food and…